Use of the Biopharmaceutics Drug Disposition Classification System (BDDCS) to Help Predict the Occurrence of Idiosyncratic Cutaneous Adverse Drug Reactions Associated with Antiepileptic Drug Usage

Journal Title: The AAPS Journal - Year 2016, Vol 18, Issue 3

Abstract

The online version of this article (doi:10.1208/s12248-016-9898-x) contains supplementary material, which is available to authorized users.

Authors and Affiliations

Rosa Chan, Chun-yu Wei, Yuan-tsong Chen, Leslie Z. Benet

Keywords

Related Articles

Fish drug analysis—Phish-pharm: A searchable database of pharmacokinetics data in fish

Information about drug residues and pharmacokinetic parameters in aquatic species is relatively sparse. In addition, it is difficult to rapidly compare data between studies due to differences in experimental conditions,...

Ethinyl Estradiol and Other Human Pharmaceutical Estrogens in the Aquatic Environment: A Review of Recent Risk Assessment Data

Interest in pharmaceuticals in the environment has increased substantially in recent years. Several studies in particular have assessed human and ecological risks from human pharmaceutical estrogens, such as 17α-...

Micro-Flow Imaging: Flow Microscopy Applied to Sub-visible Particulate Analysis in Protein Formulations

The need to monitor, measure, and control sub-visible proteinaceous particulates in biopharmaceutical formulations has been emphasized in recent publications and commentaries. Some of these particulates can be highly tra...

Ligand Binding Assays in the 21st Century Laboratory—A Call for Change

In June 2009, a group of ligand binding assay experts met in Seattle, WA to discuss the need for greater efficiency in bioanalytical laboratories. The central premise was increased utilization of technological innovation...

Download PDF file
  • EP ID EP680883
  • DOI  10.1208/s12248-016-9898-x
  • Views 51
  • Downloads 0

How To Cite

Rosa Chan, Chun-yu Wei, Yuan-tsong Chen, Leslie Z. Benet (2016). Use of the Biopharmaceutics Drug Disposition Classification System (BDDCS) to Help Predict the Occurrence of Idiosyncratic Cutaneous Adverse Drug Reactions Associated with Antiepileptic Drug Usage. The AAPS Journal, 18(3), -. https://europub.co.uk/articles/-A-680883